HealthMyne’s technology as a radiomics tool to inform clinical decision-making, identify imaging biomarkers and predict tumor response to cancer treatment was validated by Cancer Control, the company announced recently. “By extracting…

HealthMyne is collaborating with RefleXion, a therapeutic oncology company, to bring together their technologies to quantify and improve cancer treatment, the company announced recently. According to a release, RefleXion will…

Rose Higgins is joining HealthMyne as its new CEO, the organization announced this week. According to a release, Higgins replaces Arvind Subramanian, who retired after taking the helm in September…